Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins

Annals of Biomedical Engineering

Volumn 39, Issue 8, 2011, Pages 2213-2222

  Rivera, Corban G ^a   Bader, Joel S ^a   Popel, Aleksander S ^a  

^a Johns Hopkins University   (United States)

Author keywords

Angiogenesis; Crosstalk; CXC chemokine; Interactome; Syndecan; Thrombospondin 1; Type IV collagen

Indexed keywords

ANGIOGENESIS; CHEMOKINES; INTERACTOME; SYNDECAN; THROMBOSPONDIN-1; TYPE IV COLLAGEN;

BIOINFORMATICS; COLLAGEN; DISEASES; GENE EXPRESSION; GRAPH THEORY; PEPTIDES; SIGNALING; TIME SERIES; TIME SERIES ANALYSIS;

CROSSTALK;

ALPHA CHEMOKINE; CD44 PROTEIN, HUMAN; COLLAGEN TYPE 4; GELATINASE B; HERMES ANTIGEN; THROMBOSPONDIN 1; VCAN PROTEIN, HUMAN; VERSICAN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD44; CHEMOKINES, CXC; COLLAGEN TYPE IV; HUMANS; MATRIX METALLOPROTEINASE 9; MODELS, CARDIOVASCULAR; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1; VERSICANS;

EID: 80051547835     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-011-0325-2     Document Type: Article

References (38)

1. AR Albig JR Neil WP Schiemann 2006 Fibulins 3 and 5 antagonize tumor angiogenesis in vivo Cancer Res. 66 5 2621 2629 16510581 10.1158/0008-5472.CAN- 04-4096 1:CAS:528:DC%2BD28XhvV2hu78%3D
2. M Ashburner CA Ball JA Blake, et al. 2000 Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 25 1 25 29 10802651 10.1038/75556 1:CAS:528:DC%2BD3cXjtFSlsbc%3D (Pubitemid 30257031)
3. S Bauer S Grossmann M Vingron, et al. 2008 Ontologizer 2.0-a multifunctional tool for GO term enrichment analysis and data exploration Bioinformatics 24 14 1650 1651 18511468 10.1093/bioinformatics/btn250 1:CAS:528:DC%2BD1cXosVymtLo%3D (Pubitemid 351966169)
4. BJ Breitkreutz C Stark T Reguly, et al. 2008 The BioGRID Interaction Database: 2008 update Nucleic Acids Res. 36 Database issue D637 D640 18000002 1:CAS:528:DC%2BD1cXhtVSrsLk%3D
5. V Cano Mdel ED Karagiannis M Soliman, et al. 2009 A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization Invest. Ophthalmol. Vis. Sci. 50 8 3840 3845 19279315 10.1167/iovs.08-2607
6. G Cao RC Savani M Fehrenbach, et al. 2006 Involvement of endothelial CD44 during in vivo angiogenesis Am. J. Pathol. 169 1 325 336 16816384 10.2353/ajpath.2006.060206 1:CAS:528:DC%2BD28XnslSntbk%3D
7. J Folkman 1971 Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 21 1182 1186 4938153 10.1056/NEJM197111182852108 1:STN:280: DyaE38%2FgvVCqsQ%3D%3D
8. J Folkman 2007 Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discov. 6 4 273 286 17396134 10.1038/nrd2115 1:CAS:528: DC%2BD2sXjs1SisL4%3D (Pubitemid 46505878)
9. M Gioia S Monaco PE Van Den Steen, et al. 2009 The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B J. Mol. Biol. 386 2 419 434 19109975 10.1016/j.jmb.2008.12.021 1:CAS:528: DC%2BD1MXhs1ars74%3D
10. M Jayapandian A Chapman VG Tarcea, et al. 2007 Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together Nucleic Acids Res. 35 Database issue D566 D571 17130145 10.1093/nar/gkl859 1:CAS:528: DC%2BD2sXivFGqsA%3D%3D (Pubitemid 46056271)
11. ED Karagiannis AS Popel 2004 A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2 J. Biol. Chem. 279 37 39105 39114 15252025 10.1074/jbc.M403627200 1:CAS:528:DC%2BD2cXnt1yjtrw%3D (Pubitemid 39296073)
12. ED Karagiannis AS Popel 2007 Anti-angiogenic peptides identified in thrombospondin type I domains Biochem. Biophys. Res. Commun. 359 1 63 69 17531201 10.1016/j.bbrc.2007.05.041 1:CAS:528:DC%2BD2sXmtFKqtLY%3D (Pubitemid 46839218)
13. ED Karagiannis AS Popel 2007 Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells Int. J. Biochem. Cell Biol. 39 12 2314 2323 17707681 10.1016/j.biocel.2007.06.018 1:CAS:528:DC%2BD2sXhtFWgsLrI (Pubitemid 47484285)
14. ED Karagiannis AS Popel 2008 A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells Proc. Natl. Acad. Sci. USA 105 37 13775 13780 18780781 10.1073/pnas.0803241105 1:CAS:528:DC%2BD1cXhtFKiurvM
15. ED Karagiannis AS Popel 2008 Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines J. Cell. Biochem. 104 4 1356 1363 18307172 10.1002/jcb.21712 1:CAS:528:DC%2BD1cXosFykt7g%3D (Pubitemid 351961706)
16. TS Keshava Prasad R Goel K Kandasamy, et al. 2009 Human Protein Reference Database-2009 update Nucleic Acids Res. 37 Database issue D767 D772 18988627 10.1093/nar/gkn892 1:STN:280:DC%2BD1M%2FitVCluw%3D%3D
17. S Killcoyne GW Carter J Smith, et al. 2009 Cytoscape: a community-based framework for network modeling Methods Mol. Biol. 563 219 239 19597788 10.1007/978-1-60761-175-2-12 1:CAS:528:DC%2BC3cXhvVKhu7c%3D
18. JE Koskimaki ED Karagiannis EV Rosca, et al. 2009 Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts Neoplasia 11 12 1285 1291 20019836 1:CAS:528: DC%2BD1MXhsFejurjP
19. JE Koskimaki ED Karagiannis BC Tang, et al. 2010 Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model BMC Cancer 10 29 20122172 10.1186/1471-2407-10-29 1:CAS:528:DC%2BC3cXhs12gt7s%3D
20. HJ Kuo CL Maslen DR Keene, et al. 1997 Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen J. Biol. Chem. 272 42 26522 26529 9334230 10.1074/jbc.272.42.26522 1:CAS:528: DyaK2sXmvV2isbs%3D (Pubitemid 27458872)
21. Y Li P Agarwal D Rajagopalan 2008 A global pathway crosstalk network Bioinformatics 24 12 1442 1447 18434343 10.1093/bioinformatics/btn200 1:CAS:528:DC%2BD1cXnt1SlurY%3D (Pubitemid 351850998)
22. MF McCarty 2006 Toward prevention of Alzheimers disease-potential nutraceutical strategies for suppressing the production of amyloid beta peptides Med. Hypotheses 67 4 682 697 16828233 10.1016/j.mehy.2006.04.067 1:CAS:528:DC%2BD28XntFSht7g%3D (Pubitemid 44062158)
23. S Mellberg A Dimberg F Bahram, et al. 2009 Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis FASEB J. 23 5 1490 1502 19136612 10.1096/fj.08-123810 1:CAS:528:DC%2BD1MXlsFSms7o%3D
24. E Mira RA Lacalle JM Buesa, et al. 2004 Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface J. Cell Sci. 117 Pt 9 1847 1857 15075244 10.1242/jcs.01035 1:CAS:528:DC%2BD2cXjvFCiuro%3D (Pubitemid 38559315)
25. H Nagase JF Woessner Jr 1999 Matrix metalloproteinases J. Biol. Chem. 274 31 21491 21494 10419448 10.1074/jbc.274.31.21491 1:CAS:528:DyaK1MXltVynu7s%3D (Pubitemid 29359963)
26. M Natarajan KM Lin RC Hsueh, et al. 2006 A global analysis of cross-talk in a mammalian cellular signalling network Nat. Cell Biol. 8 6 571 580 16699502 10.1038/ncb1418 1:CAS:528:DC%2BD28XltFWqs7s%3D (Pubitemid 43827349)
27. G Opdenakker PE Van den Steen B Dubois, et al. 2001 Gelatinase B functions as regulator and effector in leukocyte biology J. Leukoc. Biol. 69 6 851 859 11404367 1:CAS:528:DC%2BD3MXkslWrt7c%3D (Pubitemid 32577883)
28. E Ruoslahti 1981 Fibronectin J. Oral Pathol. 10 1 3 13 6782207 10.1111/j.1600-0714.1981.tb01242.x 1:CAS:528:DyaL3MXhtlChsbY%3D (Pubitemid 11138573)
29. E Schonherr C Sunderkotter L Schaefer, et al. 2004 Decorin deficiency leads to impaired angiogenesis in injured mouse cornea J. Vasc. Res. 41 6 499 508 15528932 10.1159/000081806 (Pubitemid 39656675)
30. R Silva G D'Amico KM Hodivala-Dilke, et al. 2008 Integrins: the keys to unlocking angiogenesis Arterioscler. Thromb. Vasc. Biol. 28 10 1703 1713 18658045 10.1161/ATVBAHA.108.172015 1:CAS:528:DC%2BD1cXhtFSmsrfE
31. A Subramanian P Tamayo VK Mootha, et al. 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 43 15545 15550 16199517 10.1073/pnas.0506580102 1:CAS:528:DC%2BD2MXht1ShtrnO (Pubitemid 41528093)
32. Z Suo J Humphrey A Kundtz, et al. 1998 Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo Neurosci. Lett. 257 2 77 80 9865931 10.1016/S0304-3940(98)00814-3 1:CAS:528:DyaK1cXnt1eiu7k%3D (Pubitemid 28552892)
33. VG Tarcea T Weymouth A Ade, et al. 2009 Michigan molecular interactions r2: from interacting proteins to pathways Nucleic Acids Res. 37 Database issue D642 D646 18978014 10.1093/nar/gkn722 1:CAS:528:DC%2BD1cXhsFejtb7J
34. E Tkachenko JM Rhodes M Simons 2005 Syndecans: new kids on the signaling block Circ. Res. 96 5 488 500 15774861 10.1161/01.RES.0000159708.71142.c8 1:CAS:528:DC%2BD2MXitFCgtr0%3D (Pubitemid 40463457)
35. JC Tony 2003 Alzheimer's disease and angiogenesis Lancet 361 9365 1300 12699983 10.1016/S0140-6736(03)13002-4
36. K Tsuda WS Noble 2004 Learning kernels from biological networks by maximizing entropy Bioinformatics 20 Suppl. 1 326 333 10.1093/bioinformatics/ bth906 (Pubitemid 41296706)
37. I Vastrik P D'Eustachio E Schmidt, et al. 2007 Reactome: a knowledge base of biologic pathways and processes Genome Biol. 8 3 R39 17367534 10.1186/gb-2007-8-3-r39 (Pubitemid 351851050)
38. R Zielinski PF Przytycki J Zheng, et al. 2009 The crosstalk between EGF, IGF, and Insulin cell signaling pathways-computational and experimental analysis BMC Syst. Biol. 3 88 19732446 10.1186/1752-0509-3-88